The estimated Net Worth of Louise Francesconi is at least $1.63 Milione dollars as of 28 June 2024. Ms. Francesconi owns over 4,737 units of Accelerate Diagnostics Inc stock worth over $54,028 and over the last 22 years she sold AXDX stock worth over $1,206,416. In addition, she makes $372,564 as Independent Director at Accelerate Diagnostics Inc.
Sign up
Ms. Francesconi AXDX stock SEC Form 4 insiders trading
Louise has made over 30 trades of the Accelerate Diagnostics Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 4,737 units of AXDX stock worth $7,627 on 28 June 2024.
The largest trade she's ever made was exercising 75,949 units of Accelerate Diagnostics Inc stock on 31 May 2023 worth over $122,278. On average, Louise trades about 4,165 units every 107 days since 2003. As of 28 June 2024 she still owns at least 33,558 units of Accelerate Diagnostics Inc stock.
You can see the complete history of Ms. Francesconi stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Louise Francesconi biography
Louise L. Francesconi serves as Independent Director of the Company. Before retiring, Ms. Francesconi served as President of Raytheon Missile Systems, a defense electronics corporation, from 1997 to 2008. During her tenure at Raytheon, Ms. Francesconi was named three times by Fortune Magazine to its 50 Most Powerful Women in Business list. Ms. Francesconi currently serves as a director of US Energy Corporation and as Chairman of the Board of Trustees for Tucson Medical Center, a regional hospital. Ms. Francesconi has previously served as a director of Stryker Corporation, a medical technology company. Ms. Francesconi received a B.S. degree in Economics from Scripps College and an M.B.A. from the University of California, Los Angeles.
What is the salary of Louise Francesconi?
As the Independent Director of Accelerate Diagnostics Inc, the total compensation of Louise Francesconi at Accelerate Diagnostics Inc is $372,564. There are 5 executives at Accelerate Diagnostics Inc getting paid more, with John Phillips having the highest compensation of $12,300,900.
How old is Louise Francesconi?
Louise Francesconi is 67, she's been the Independent Director of Accelerate Diagnostics Inc since 2019. There are 4 older and 10 younger executives at Accelerate Diagnostics Inc. The oldest executive at Accelerate Diagnostics Inc is Jack Schuler, 79, who is the Independent Director.
What's Louise Francesconi's mailing address?
Louise's mailing address filed with the SEC is C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON, AZ, 85714.
Insiders trading at Accelerate Diagnostics Inc
Over the last 12 years, insiders at Accelerate Diagnostics Inc have traded over $26,833,308 worth of Accelerate Diagnostics Inc stock and bought 16,366,880 units worth $209,384,489 . The most active insiders traders include Jack W Schuler, Larry N Feinberg e Matthew Strobeck. On average, Accelerate Diagnostics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $132,645. The most recent stock trade was executed by Hany Massarany on 28 June 2024, trading 4,737 units of AXDX stock currently worth $7,627.
What does Accelerate Diagnostics Inc do?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
What does Accelerate Diagnostics Inc's logo look like?
Complete history of Ms. Francesconi stock trades at Accelerate Diagnostics Inc e Stryker
Accelerate Diagnostics Inc executives and stock owners
Accelerate Diagnostics Inc executives and other stock owners filed with the SEC include:
-
John Phillips,
Chief Executive Officer, Chief Operating Officer, Director -
Steve Reichling,
Chief Financial Officer -
Jack Phillips,
CEO, Pres & Director -
Ron Price,
Senior Vice President, Head of Commercial Operations, Americas -
Roland Diggelmann,
Independent Director -
Louise Francesconi,
Independent Director -
Steve Reichling,
CFO & Chief Accounting Officer -
Ron Price,
Chief Commercial Officer of Americas -
Charles Watts,
Independent Director -
Frank ten Brink,
Independent Director -
Matthew Strobeck,
Independent Director -
Jack Schuler,
Independent Director -
Mark Miller,
Independent Director -
Thomas Brown,
Independent Director -
John Patience,
Independent Chairman of the Board -
Nedal Safwat,
Chief Strategy Officer -
Dr. Lawrence Mertz,
Sr. VP and Head of R&D -
John Meduri,
Chief Strategy Officer -
Laura Costa,
Sr. VP & Head of Global Customer Support -
Cherif Bousselham,
Sr. VP & Head of Sales - EMEA -
Gretchen Strohminger,
Sr. VP and Head of HR & Culture -
Michael Bridge,
Sr. VP, Gen. Counsel & Sec. -
Laura Pierson,
Investor Relations Officer -
Larry N Feinberg,
10% owner -
Pete Bantock,
CHIEF COMMERCIAL OFFICER -
Lawrence Mehren,
PRESIDENT AND CEO -
Marran H. Ogilvie,
Director -
Jennifer Regan,
Director -
Mark S. Black,
Director -
Ventures, Llc Abeja,
10% owner -
Romney Humphries,
Chief Scientific Officer -
Larry Michael Mertz,
Chief Technology Officer -
Hany Massarany,
Director -
Jack Phillips,
Chief Executive Officer -
Wayne Burris,
Director -
David Patience,
Chief Financial Officer